Awareness of women with diabetes mellitus about pregnancy preparation and planning
Heading: Endocrinology Article type: Original article
Authors: Rodionova T.I., Dikht N.I., Orlova M.M.
Organization: Saratov State Medical University
Objective: to assess the awareness of women with diabetes mellitus (DM) regarding pregnancy preparation and planning. Material and methods. A cross-sectional survey was conducted among 94 non-pregnant women aged 18– 45 years with type 1 and type 2 DM using an original 20-item questionnaire. Additional clinical and laboratory data were obtained from electronic medical records. Results. The majority of women with DM (81.9%) had not previously planned their pregnancy; 71% had suboptimal glycated hemoglobin levels. Unplanned pregnancies were signifcantly more often associated with threatened miscarriage (62.5% vs 18% in planned pregnancies; p=0.004). Knowledge about safe contraceptive methods in the context of DM was poor: 48% of respondents reported that they had never discussed this topic with their endocrinologist. Despite the proven efcacy and safety of low-dose combined oral contraceptives regarding carbohydrate metabolism and diabetic vascular complications, 77.6% of women preferred barrier methods. Conclusion. The study revealed insufcient awareness among women with DM regarding the importance of pregnancy planning, as well as poor knowledge about safe contraceptive methods and the target level of glycated hemoglobin.
Bibliography:
1. International Diabetes Federation. IDF Diabetes Atlas 11th edition. 2025. URL: https://diabetesatlas.org/resources/idf-diabetes-atlas-2025/ (19 Sept 2025).
2. Dedov II, Shestakova MV, Vikulova OK, et al. Diabetes mellitus in the Russian Federation: Dynamics of epidemiological indicators according to the Federal Diabetes Register for the period 2010–2022. Diabetes Mellitus. 2023;26(2):104-23. DOI:10.14341/DM13035
3. Okigbo CC, McLaughlin C, Kirkman MS. Prevalence, predictors, and consequences of unplanned pregnancy in women with preexisting diabetes. Diabetes. 2022;71(Suppl. 1):1053-P. DOI:10.2337/db22-1053-P
4. Dedov II, Krasnopolskiy VI, Sukhikh GT. Russian National Consensus Statement on gestational diabetes: diagnostics, treatment and postnatal care. Diabetes Mellitus. 2012;15(4):4-10. DOI:10.14341/2072-0351-5531
5. Wyckof JA, Lapolla A, Asias-Dinh BD, et al. Preexisting diabetes and pregnancy: An Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline. Eur J Endocrinol. 2025;193(1):G1-48. DOI:10.1093/ejendo/lvaf116
6. Arbatskaya NYu. Diabetes mellitus and pregnancy. Pharmateca. 2000;(5):30-6.
7. Peterson C, Grosse SD, Li R, et al. Preventable health and cost burden of adverse birth outcomes associated with pre-gestational diabetes in the United States. Am J Obstet Gynecol. 2015;212(1):74.e1-9. DOI:10.1016/j.ajog.2014.09.009
8. Crowe SM, Mastrobattista JM, Monga M. Oral glucose tolerance test and the preparatory diet. Am J Obstet Gynecol. 2000; 82(5):1052-4. DOI:10.1067/mob.2000.105391
9. Borovik NV, Musina EV, Tiselko AV, et al. The infuence of preconception preparation on the course and outcome of pregnancy in women with type 2 diabetes mellitus. Journal of Obstetrics and Women’s Diseases. 2021;70(3):11-9. DOI: 10.17816/JOWD58667
10. Curtis KM, Jatlaoui TC, Tepper NK, et al. U.S. Selected Practice Recommendations for contraceptive use, 2016. MMWR Recomm Rep. 2016;65(4):1-66. DOI:10.15585/mmwr.rr6504a1
11. Grigoryan OR, Andreeva EN. Comparative analysis of the efect of combined oral contraceptives on carbohydrate and lipid metabolism in women with type 1 diabetes of reproductive period. Reproduction Problems. 2014;(3):20-5.
12. Bailey SC, Pack AP, Wismer G, et al. Promoting REproductive Planning And REadiness in Diabetes (PREPARED) Study protocol: A clinic-randomised controlled trial testing a technology-based strategy to promote preconception care for women with
type 2 diabetes. BMJ Open. 2023;13(11):e078282. DOI:10.1136/bmjopen-2023-078282
13. Pilszyk A, Smith J, Jones B, et al. Incretins as a potential treatment option for gestational diabetes mellitus. Int J Mol Sci. 2022;23(17):10101. DOI:10.3390/ijms231710101
14. American College of Obstetricians and Gynecologists (ACOG). Obesity in pregnancy: ACOG practice bulletin, number 230. Obstet Gynecol. 2021;137(6):e128-44. DOI:10.1097/AOG.0000000000004395
15. On approval of the distribution of subsidies provided in 2024 from the federal budget to the budgets of the constituent entities of the Russian Federation for the purpose of co-fnancing expenditure obligations for the fnancial support for the implementation of measures to provide pregnant women in need with continuous glucose monitoring systems within the framework of the federal project “Combating Diabetes Mellitus”. URL: https:// www.consultant.ru/document/cons_doc_LAW_490578/f62ee45f-aefd8e2a11d6d88941ac66824f848bc2/ (15 Oct 2025).
16. Feig DS, Donovan LE, Corcoy R, et al. Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): A multicenter international randomized controlled trial. Lancet. 2017;390(10110):2347-59. DOI:10.1016/S0140-6736(17)32400-5
17. Dedov II, Shestakova MV, Sukhareva OYu, eds. Algorithms of specialized medical care for patients with diabetes mel-litus. 12th edition. Moscow: [s. n.], 2025; 247 p. DOI:10.14341/algdc2025
| Attachment | Size |
|---|---|
| 02_maket_198-204.pdf | 727.98 KB |



